Log Out
 

This year’s CONy featured intriguing debates on alternative modes of treatment for migraine—an extremely debilitating disorder affecting 1 in 10 individuals globally.1 With several new prophylactic treatments currently available, opportunities are emerging for easing the burden of suffering in patients with migraine.

In a session hosted by Dr. Robert E. Shapiro (University of Vermont, VT, USA), migraine experts Drs. Steven M. Baskin (New England Institute for Neurology and Headache, Stamford, CT, USA) and Mark Braschinsky (Tartu University Hospital, Headache Clinic, Estonia) debated whether cognitive behavioral therapy (CBT) and biofeedback training can be as effective as medication in the prophylactic treatment of migraine.

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis of the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-602.

  2. Mitsikostas DD, Rapoport AM. New players in the preventive treatment of migraine. BMC Med. 2015;13:279. doi: 10.1186/s12916-015-0522-1.